Skip to main navigation Skip to search Skip to main content

Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous mice

  • Randy Strong
  • , Richard A. Miller
  • , Catherine J. Cheng
  • , James F. Nelson
  • , Jonathan Gelfond
  • , Shailaja Kesaraju Allani
  • , Vivian Diaz
  • , Angela Olsen Dorigatti
  • , Jonathan Dorigatti
  • , Elizabeth Fernandez
  • , Andrzej Galecki
  • , Brett Ginsburg
  • , Karyn L. Hamilton
  • , Martin A. Javors
  • , Kerry Kornfeld
  • , Matt Kaeberlein
  • , Suja Kumar
  • , David B. Lombard
  • , Marisa Lopez-Cruzan
  • , Benjamin F. Miller
    • Peter Rabinovitch, Peter Reifsnyder, Nadia A. Rosenthal, Molly A. Bogue, Adam B. Salmon, Yousin Suh, Eric Verdin, Herbert Weissbach, John Newman, Francesca Maccchiarini, David E. Harrison

Research output: Contribution to journal › Article › peer-review

44   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous mice'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science